Dosage forms with an enterically coated core tablet

Details for Australian Patent Application No. 2005266882 (hide)

Owner Teva Pharmaceutical Indudstries, Ltd.

Inventors Rosenberger, Vered; Flashner-Barak, Moshe; Lerner, E. Itzhak; Aqua, Ofer

Agent Shelston IP

Pub. Number AU-A-2005266882

PCT Pub. Number WO2006/012634

Priority 60/591,482 26.07.04 US; 60/591,820 27.07.04 US

Filing date 26 July 2005

Wipo publication date 2 February 2006

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/00 (2006.01)

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4458 (2006.01) - only substituted in position 2, e.g. methylphenidate

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012634 Priority application(s): WO2006/012634

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266887-Method of diagnosing, monitoring and treating pulmonary diseases

2005266875-ActRII receptor polypeptides, methods and compositions